These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38464892)

  • 1. Magnetic resonance imaging based kidney volume assessment for risk stratification in pediatric autosomal dominant polycystic kidney disease.
    Yilmaz K; Saygili S; Canpolat N; Akgun-Dogan O; Yuruk Yildirim ZN; Cicek-Oksuz RY; Oner HA; Aksu B; Akyel NG; Oguzhan-Hamis O; Dursun H; Yavuz S; Cicek N; Akinci N; Karabag Yilmaz E; Agbas A; Nayir AN; Konukoglu D; Kurugoglu S; Sever L; Caliskan S
    Front Pediatr; 2024; 12():1357365. PubMed ID: 38464892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.
    Sans L; Radosevic A; Quintian C; Montañés R; Gràcia S; Vilaplana C; Mojal S; Ballarin JA; Fernández-Llama P; Torra R; Pascual J
    PLoS One; 2017; 12(3):e0174583. PubMed ID: 28346513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry.
    Breysem L; De Keyzer F; Schellekens P; Dachy A; De Rechter S; Janssens P; Vennekens R; Bammens B; Irazabal MV; Van Ongeval C; Harris PC; Mekahli D;
    Clin J Am Soc Nephrol; 2023 Feb; 18(5):581-91. PubMed ID: 36800517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.
    Higashihara E; Yamamoto K; Kaname S; Okegawa T; Tanbo M; Yamaguchi T; Shigemori K; Miyazaki I; Yokoyama K; Nutahara K
    Clin Exp Nephrol; 2019 Jan; 23(1):100-111. PubMed ID: 30097754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with Protein-Truncating
    Lanktree MB; Guiard E; Akbari P; Pourafkari M; Iliuta IA; Ahmed S; Haghighi A; He N; Song X; Paterson AD; Khalili K; Pei YPC
    Clin J Am Soc Nephrol; 2021 Mar; 16(3):374-383. PubMed ID: 33602752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.
    Alzahrani OR; Alatwi HE; Alharbi AA; Alessa AH; Al-Amer OM; Alanazi AFR; Shams AM; Alomari E; Naser AY; Alzahrani FA; Hosawi S; Alghamdi SM; Abdali WA; Elfaki I; Hawsawi YM
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
    Sans L; Pascual J; Radosevic A; Quintian C; Ble M; Molina L; Mojal S; Ballarin JA; Torra R; Fernández-Llama P
    Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
    Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
    Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.
    Phakdeekitcharoen B; Treesinchai W; Wibulpolprasert P; Boongird S; Klytrayong P
    BMC Nephrol; 2021 May; 22(1):178. PubMed ID: 33992075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
    Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
    Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease.
    Chang AR; Moore BS; Luo JZ; Sartori G; Fang B; Jacobs S; Abdalla Y; Taher M; Carey DJ; Triffo WJ; Singh G; Mirshahi T
    JAMA; 2022 Dec; 328(24):2412-2421. PubMed ID: 36573973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of Seminal Megavesicles, Prostate Median Cysts, and Genotype in Autosomal Dominant Polycystic Kidney Disease.
    Zhang W; Stephens CJ; Blumenfeld JD; Behzadi AH; Donahue S; Bobb WO; Newhouse JH; Rennert H; Zhao Y; Prince MR
    J Magn Reson Imaging; 2019 Mar; 49(3):894-903. PubMed ID: 30230107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
    Chapman AB; Bost JE; Torres VE; Guay-Woodford L; Bae KT; Landsittel D; Li J; King BF; Martin D; Wetzel LH; Lockhart ME; Harris PC; Moxey-Mims M; Flessner M; Bennett WM; Grantham JJ
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):479-86. PubMed ID: 22344503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis.
    Sierks D; Schönauer R; Friedrich A; Hantmann E; de Fallois J; Linder N; Fischer J; Herber A; Bergmann C; Berg T; Halbritter J
    JHEP Rep; 2022 Nov; 4(11):100579. PubMed ID: 36246085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple urinary tract infections are associated with genotype and phenotype in adult polycystic kidney disease.
    Eroglu E; Kocyigit I; Cetin M; Zararsiz G; Imamoglu H; Bayramov R; Tastan S; Sipahioglu MH; Tokgoz B; Oymak O
    Clin Exp Nephrol; 2019 Oct; 23(10):1188-1195. PubMed ID: 31165946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DKK3 as a potential novel biomarker in patients with autosomal polycystic kidney disease.
    Arjune S; Späth MR; Oehm S; Todorova P; Schunk SJ; Lettenmeier K; Chon SH; Bartram MP; Antczak P; Grundmann F; Fliser D; Müller RU
    Clin Kidney J; 2024 Jan; 17(1):sfad262. PubMed ID: 38186869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.
    Cadnapaphornchai MA; George DM; McFann K; Wang W; Gitomer B; Strain JD; Schrier RW
    Clin J Am Soc Nephrol; 2014 May; 9(5):889-96. PubMed ID: 24721893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.
    Bae KT; Zhou W; Shen C; Landsittel DP; Wu Z; Tao C; Chapman AB; Torres VE; Yu ASL; Mrug M; Bennett WM; Harris PC;
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):823-833. PubMed ID: 31088850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
    Kocyigit I; Eroglu E; Kaynar AS; Kocer D; Kargi S; Zararsiz G; Bayramov R; Imamoglu H; Sipahioglu MH; Tokgoz B; Dundar M; Oymak O
    J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.